Literature DB >> 30590561

Comprehensive evaluation of structural and functional myocardial impairments in Becker muscular dystrophy using quantitative cardiac magnetic resonance imaging.

Benjamin Marty1,2, Raymond Gilles3, Marcel Toussaint1,2, Anthony Béhin4, Tanya Stojkovic4, Bruno Eymard4, Pierre G Carlier1,2, Karim Wahbi4.   

Abstract

AIMS: Becker muscular dystrophy (BMD) is a genetic neuromuscular disease characterized by an alteration of the dystrophin protein. Myocardial involvement is frequent, eventually progressing to a dilated cardiomyopathy, and represents the most common cause of death for this pathology. We performed a comprehensive evaluation of myocardial functional and structural alterations encountered in a large cohort of BMD patients using quantitative cardiac magnetic resonance (CMR) imaging. METHODS AND
RESULTS: Eighty-eight BMD patients and 26 age-matched volunteers underwent standard cine and tag imaging to assess myocardial function and dyssynchrony, while native T1, T2, and extracellular volume fraction (ECV) were measured for tissue characterization. The left ventricular ejection fraction (LV-EF) was significantly reduced in 26% of the BMD patients. Patients exhibited higher dyssynchrony index than controls (6.94 ± 3.17 vs. 5.09 ± 1.25, P = 0.005). Diastolic dyssynchrony also exists in patients where systolic function was normal. BMD subjects, compared with controls, had significantly higher native T1, T2, and ECV (1183 ± 60 ms vs. 1164 ± 22 ms, 47.5 ± 4.5 ms vs. 45.6 ± 3.4 ms, 0.282 ± 0.050 vs. 0.231 ± 0.027, respectively, P < 0.05). Native T1, T2, and ECV correlated with LV-EF (R = -0.79, -0.70, and -0.71, respectively, P < 0.001) and N-terminal-pro brain natriuretic peptide (R = 0.51, 0.58, and 0.44, respectively, P < 0.001).
CONCLUSION: Quantitative CMR represents a powerful tool to evaluate structural and functional impairments in the myocardium of BMD subjects. Native T1, T2, and ECV provided quantitative biomarkers related to inflammation and fibrosis, and could stratify disease severity. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Becker muscular dystrophy; cardiomyopathy; clinical study; magnetic resonance imaging; relaxometry

Year:  2019        PMID: 30590561     DOI: 10.1093/ehjci/jey209

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  4 in total

Review 1.  Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging.

Authors:  Georgios M Alexandridis; Efstathios D Pagourelias; Nikolaos Fragakis; Maria Kyriazi; Efthymia Vargiami; Dimitrios Zafeiriou; Vassilios P Vassilikos
Journal:  Heart Fail Rev       Date:  2022-07-20       Impact factor: 4.654

Review 2.  The Added Value of Cardiac Magnetic Resonance in Muscular Dystrophies.

Authors:  Mariana M Lamacie; Jodi Warman-Chardon; Andrew M Crean; Anca Florian; Karim Wahbi
Journal:  J Neuromuscul Dis       Date:  2019

3.  Causes of clinical variability in Duchenne and Becker muscular dystrophies and implications for exon skipping therapies.

Authors:  Eric P Hoffman
Journal:  Acta Myol       Date:  2020-12-01

4.  Improved Cardiac Outcomes by Early Treatment with Angiotensin-Converting Enzyme Inhibitors in Becker Muscular Dystrophy.

Authors:  Caroline Stalens; Leslie Motté; Anthony Béhin; Rabah Ben Yaou; France Leturcq; Guillaume Bassez; Pascal Laforêt; Bertrand Fontaine; Stéphane Ederhy; Marion Masingue; Malika Saadi; Sarah Leonard Louis; Nawal Berber; Tanya Stojkovic; Denis Duboc; Karim Wahbi
Journal:  J Neuromuscul Dis       Date:  2021
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.